Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Whitcup SM, Fortin E, Lindblad AS, Griffiths P, Metcalf JA, Robinson MR, Manischewitz J, Baird B, Perry C, Kidd IM, Vrabec T, Davey RT Jr, Falloon J, Walker RE, Kovacs JA, Lane HC, Nussenblatt RB, Smith J, Masur H, Polis MA. Whitcup SM, et al. Among authors: fortin e. JAMA. 1999 Nov 3;282(17):1633-7. doi: 10.1001/jama.282.17.1633. JAMA. 1999. PMID: 10553789 Clinical Trial.
Strategies for the treatment of intraocular inflammatory disease.
Nussenblatt RB, Schiffman R, Fortin E, Robinson M, Smith J, Rizzo L, Csaky K, Gery I, Waldmann T, Whitcup SM. Nussenblatt RB, et al. Among authors: fortin e. Transplant Proc. 1998 Dec;30(8):4124-5. doi: 10.1016/s0041-1345(98)01364-5. Transplant Proc. 1998. PMID: 9865319 Review. No abstract available.
Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial.
Nussenblatt RB, Fortin E, Schiffman R, Rizzo L, Smith J, Van Veldhuisen P, Sran P, Yaffe A, Goldman CK, Waldmann TA, Whitcup SM. Nussenblatt RB, et al. Among authors: fortin e. Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7462-6. doi: 10.1073/pnas.96.13.7462. Proc Natl Acad Sci U S A. 1999. PMID: 10377437 Free PMC article. Clinical Trial.
Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III.
Suhler EB, Adán A, Brézin AP, Fortin E, Goto H, Jaffe GJ, Kaburaki T, Kramer M, Lim LL, Muccioli C, Nguyen QD, Van Calster J, Cimino L, Kron M, Song AP, Liu J, Pathai S, Camez A, Schlaen A, van Velthoven MEJ, Vitale AT, Zierhut M, Tari S, Dick AD. Suhler EB, et al. Among authors: fortin e. Ophthalmology. 2018 Jul;125(7):1075-1087. doi: 10.1016/j.ophtha.2017.12.039. Epub 2018 Feb 9. Ophthalmology. 2018. PMID: 29429764 Free article. Clinical Trial.
Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis.
Suhler EB, Jaffe GJ, Fortin E, Lim LL, Merrill PT, Dick AD, Brezin AP, Nguyen QD, Thorne JE, Van Calster J, Cimino L, Adan A, Goto H, Kaburaki T, Kramer M, Vitale AT, Kron M, Song AP, Liu J, Pathai S, Douglas KM, Schlaen A, Muccioli C, Van Velthoven MEJ, Zierhut M, Rosenbaum JT. Suhler EB, et al. Among authors: fortin e. Ophthalmology. 2021 Jun;128(6):899-909. doi: 10.1016/j.ophtha.2020.10.036. Epub 2020 Nov 3. Ophthalmology. 2021. PMID: 33157077 Free article. Clinical Trial.
Multiformic modulation of endotoxin effects by linomide.
Shalev M, Ko A, Gelderman MP, Fortin E, Reed G, Slavin S, Gery I. Shalev M, et al. Among authors: fortin e. Clin Immunol. 1999 Dec;93(3):250-5. doi: 10.1006/clim.1999.4800. Clin Immunol. 1999. PMID: 10600336
136 results